Nieuwenhuizen; Willem Ferdinand

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nieuwenhuizen; Willem Ferdinand.The latest application filed is for "use of sphingomyelin and non-digestible carbohydrates for improving intestinal microbiota".

Company Profile

0.4.10

Nieuwenhuizen; Willem Ferdinand - Bunnik N/A NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Sphingolipids for improvement of the composition of the intestinal flora Grant 8,703,172 - Nieuwenhuizen April 22, 2	2014-04-22
Use of sphingolipids for reducing high plasma cholesterol and high triacylglycerol levels Grant 7,968,529 - Nieuwenhuizen June 28, 2	2011-06-28
Sphingolipids in treatment and prevention of steatosis and of steatosis or of hepatotoxicity and its sequelae Grant 7,906,488 - Nieuwenhuizen March 15, 2	2011-03-15
Use Of Sphingomyelin And Non-digestible Carbohydrates For Improving Intestinal Microbiota App 20110034407 - Nieuwenhuizen; Willem Ferdinand ; et al.	2011-02-10
Use Of Non-digestible Carbohydrates For Improving Intestinal Microbiota App 20110009359 - Amor; Kaouther Ben ; et al.	2011-01-13
Use Of Sphingolipids In The Treatment Of Type 2 Diabetes Mellitus, Insulin Resistance And Metabolic Syndrome App 20110003772 - Nieuwenhuizen; Willem Ferdinand ; et al.	2011-01-06
Use Of Sphingolipids In The Treatment And Prevention Of Type 2 Diabetes Mellitus, Insulin Resistance And Metabolic Syndrome App 20090203651 - Nieuwenhuizen; Willem Ferdinand ; et al.	2009-08-13
Sphingolipids in Treatment and Prevention of Steatosis and of Steatosis or of Hepatotoxicity and its Sequelae App 20080182902 - Nieuwenhuizen; Willem Ferdinand ; et al.	2008-07-31
Use Of Sphingolipids For Prevention And Treatment Of Atherosclerosis App 20080085939 - Nieuwenhuizen; Willem Ferdinand ; et al.	2008-04-10
Use of Sphingolipids in the Treatment and Prevention of Type 2 Diabetes Mellitus, Insulin Resistance and Metabolic Syndrome App 20070207983 - Nieuwenhuizen; Willem Ferdinand ; et al.	2007-09-06
Use of sphingolipids for reducing plasma cholesterol and triacylglycerol levels App 20060189575 - Nieuwenhuizen; Willem Ferdinand	2006-08-24
Sphingolipids for improvement of the composition of the intestinal flora App 20060134182 - Nieuwenhuizen; Willem Ferdinand	2006-06-22
Use of sphingomyelin and lyso-sphingomyelin as absorption enhancers App 20060128666 - Nieuwenhuizen; Willem Ferdinand	2006-06-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.